110 related articles for article (PubMed ID: 26944387)
1. Postoperative renormalization of C-reactive protein with adjuvant lienal polypeptide and its association with tumour recurrence in T1 clear cell renal cell carcinoma.
Guo Y; Hu Q; Sun C; Gu B; Xu K; Xia G
J Int Med Res; 2016 Jun; 44(3):620-6. PubMed ID: 26944387
[TBL] [Abstract][Full Text] [Related]
2. Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
de Martino M; Klatte T; Seemann C; Waldert M; Haitel A; Schatzl G; Remzi M; Weibl P
BJU Int; 2013 Jun; 111(8):E348-53. PubMed ID: 23495750
[TBL] [Abstract][Full Text] [Related]
3. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.
Zhao J; Zhu Y; Zhang C; Wang X; He H; Wang H; Wu Y; Zhou W; Shen Z
Urol Oncol; 2013 Nov; 31(8):1800-5. PubMed ID: 22658883
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
Can C; Acikalin MF; Ozen A; Dundar E
Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
9. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
11. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma.
Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J
Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein may represent sensitive measure of renal cell carcinoma metastasis.
Johnson TV; Young AN; Force S; Master VA
Urol Nurs; 2011; 31(3):181-2, 194. PubMed ID: 21805757
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
14. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
15. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
[TBL] [Abstract][Full Text] [Related]
16. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
Omae K; Kondo T; Tanabe K
Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
[TBL] [Abstract][Full Text] [Related]
17. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
18. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
[TBL] [Abstract][Full Text] [Related]
20. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
